Pharming Group N.V. (PHAR) Net income 2019–2025
Pharming Group N.V. (PHAR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$2.9MFY2025 · since FY2019: $40.6M → $2.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.9M | +124.1% |
| FY2024 | -$11.8M | -12.3% |
| FY2023 | -$10.5M | -177.1% |
| FY2022 | $13.7M | -14.5% |
| FY2021 | $16.0M | -57.6% |
| FY2020 | $37.7M | -6.9% |
| FY2019 | $40.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice